SCHEMBL645509

SCHEMBL645509

CN(c1ccccc1C(=O)O)S(=O)(=O)c1ccc(Cl)c(Cl)c1

nearest known ligand 0.58

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.58
GAA P10253 3/20 0.53
KDM4E B2RXH2 3/20 0.53
ALDH1A1 P00352 2/20 0.53
GLA P06280 1/20 0.53
HPGD P15428 1/20 0.53
KMT2A Q03164 6/20 0.53
ALPL P05186 1/20 0.53
ALPI P09923 1/20 0.53
ALPG P10696 1/20 0.53
MEN1 O00255 5/20 0.50
C5AR1 P21730 1/20 0.49
ACLY P53396 2/20 0.48
PRSS1 P07477 1/20 0.48
ADRB2 P07550 1/20 0.46
RECQL P46063 1/20 0.46
LMNA P02545 1/20 0.46
POLB P06746 1/20 0.45
RAB9A P51151 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL643844 0.86 KMT2A (0.59) TDP1GAAKDM4EALDH1A1KMT2A
SCHEMBL28666678 0.82 TDP1 (0.59) TDP1GAAKDM4EKMT2AMEN1
SCHEMBL645178 0.81 KMT2A (0.46) KDM4EALDH1A1KMT2AALPLALPI
SCHEMBL11418826 0.79 TDP1 (0.56) TDP1GAAKDM4EALDH1A1HPGD
SCHEMBL14033416 0.79 KMT2A (0.44) KDM4EALDH1A1KMT2AALPLALPI
SCHEMBL493681 0.78 KMT2A (0.50) KDM4EALDH1A1KMT2AALPLALPI
SCHEMBL13577031 0.75 KMT2A (0.55) TDP1GAAKDM4EALDH1A1KMT2A
SCHEMBL644106 0.75 KMT2A (0.48) GAAKDM4EALDH1A1KMT2AALPL
SCHEMBL7691842 0.75 C5AR1 (0.57) TDP1GAAGLAKMT2AMEN1
SCHEMBL14033453 0.73 KMT2A (0.46) TDP1GAAKDM4EALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8119633-B2 N-{2-[2-(4-benzyl-4-hydroxy-piperidin-1-yl)-2-oxo-ethoxy]-ethyl}-N-ethyl-4-methoxy-2,3,6-trimethyl-phenylsulfonamide; condensing the N-carboxyalkyl phenylsulfonamide with the substituted piperidine; bradykinin receptor antagonists; analgesics; antidiabetics; angiogenesis inhibitors; rheumatic diseases GRUENENTHAL GMBH (DE) 2012-02-21 US disclosed
US-20080312231-A1 Substituted Sulfonamide Compounds GRUENENTHAL GMBH (DE) 2008-12-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080312231-A1 Substituted Sulfonamide Compounds SULT2A1, SULT1A1, SCN1A TDP1 4140/4885GAA 260/4885KDM4E 2875/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.